Federal award
SAREPTA THERAPEUTICS, INC.
W9113M10C0056
Contract
Obligated and Ceiling
- Obligated (net)
- $106,393,196.17
- Ceiling (potential value, not spending)
- $260,814,992.45
- Current value
- $106,393,196.17
- Gross positive obligations
- $107,493,887.77
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SAREPTA THERAPEUTICS, INC. · YKM9HZ3EH6X1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SAREPTA THERAPEUTICS, INC. · FVMHHCGQKM83
- Awarding agency
- Department of War · sub-agency 2100 · office W911QY
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- W9113M10C0056
- Award type code
- D
- Actions
- 30 · Jul 14, 2010 to Jul 12, 2016
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History30
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 12, 2016 | FY2016 | P00029 | F | −$497,058.69 | — |
| Sep 9, 2014 | FY2014 | P00028 | B | $0.00 | — |
| Aug 6, 2014 | FY2014 | P00027 | C | $561,033.47 | — |
| Jun 30, 2014 | FY2014 | P00026 | B | $0.00 | — |
| Apr 21, 2014 | FY2014 | P00025 | C | $1,102,523.46 | — |
| Mar 28, 2014 | FY2014 | P00024 | B | $3,467,615.48 | — |
| Feb 12, 2014 | FY2014 | P00023 | C | $632,384.52 | — |
| Aug 30, 2013 | FY2013 | P00022 | B | $0.00 | — |
| Jul 11, 2013 | FY2013 | P00021 | M | $0.00 | — |
| Jul 8, 2013 | FY2013 | P00020 | C | $433,470.88 | — |
| Jul 2, 2013 | FY2013 | P00019 | C | $2,142,968.82 | — |
| May 21, 2013 | FY2013 | P00018 | C | $5,000,000.00 | — |
| May 13, 2013 | FY2013 | P00017 | D | $0.00 | — |
| Dec 5, 2012 | FY2013 | P00016 | D | $0.00 | — |
| Nov 9, 2012 | FY2013 | P00015 | C | −$603,632.91 | — |
| Sep 28, 2012 | FY2012 | P00014 | B | $0.00 | — |
| Sep 4, 2012 | FY2012 | P00013 | B | $0.00 | — |
| Aug 27, 2012 | FY2012 | P00012 | M | $0.00 | — |
| Aug 3, 2012 | FY2012 | P00011 | D | $0.00 | — |
| Jul 25, 2012 | FY2012 | P00010 | C | $5,761,089.56 | — |
| Jul 24, 2012 | FY2012 | P00009 | W | $0.00 | — |
| Jul 7, 2012 | FY2012 | P00008 | C | $849,962.46 | — |
| Apr 23, 2012 | FY2012 | P00007 | C | $13,892,639.44 | — |
| Dec 2, 2011 | FY2012 | P00006 | C | $7,350,000.00 | — |
| Sep 26, 2011 | FY2011 | P00005 | C | $0.00 | — |
| Sep 23, 2011 | FY2011 | P00004 | C | $1,162,486.68 | — |
| Aug 19, 2011 | FY2011 | P00003 | C | $3,000,000.00 | — |
| Jun 15, 2011 | FY2011 | P00002 | D | $18,900,000.00 | — |
| Apr 15, 2011 | FY2011 | P00001 | C | $16,795,984.00 | — |
| Jul 14, 2010 | FY2010 | 0 | — | $26,441,729.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.